Ragnhild Bergene Skråstad
Ragnhild Bergene Skråstad
Førsteamanuensis
Institutt for klinisk og molekylær medisin Fakultet for medisin og helsevitenskapBakgrunn og aktiviteter
Vitenskapelig, faglig og kunstnerisk arbeid
Et utvalg av nyere tidsskriftspublikasjoner, kunstneriske produksjoner, bok, inklusiv bokdeler og rapport-del. Se alle publikasjoner i databasen
Tidsskriftspublikasjoner
- (2018) Placental inflammation by HMGB1 activation of TLR4 at the syncytium. Placenta. vol. 72-73.
- (2018) Breastfeeding and long‐term maternal metabolic health in the HUNT Study: a longitudinal population‐based cohort study. BJOG: an International Journal of Obstetrics and Gynaecology. vol. 126 (4).
- (2017) Hight throughput UHPC-MSMS method for the analysis of phosphatidylethanol (PEth) 16:0/18:1, a specific biomarker for alcohol consumption, in whole blood. Journal of Analytical Toxicology. vol. 42 (1).
- (2016) Nye markører for påvisning av alkoholbruk. Tidsskrift for Den norske legeforening. vol. 136 (19).
- (2016) Foretrukne smertestillende legemidler til ammende. Norsk Farmaceutisk Tidsskrift.
- (2015) First trimester urine and serum metabolomics to predict preeclampsia and gestational hypertension. Pregnancy Hypertension. vol. 5.
- (2015) First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study. International Journal of Molecular Sciences. vol. 16 (9).
- (2015) Risk assessment for preeclampsia in nulliparous women at 11 to 13 weeks gestational age: prospective evaluation of two algorithms. BJOG: an International Journal of Obstetrics and Gynaecology. vol. 122 (13).
- (2015) Distinct First Trimester Cytokine Profiles for Gestational Hypertension and Preeclampsia. Arteriosclerosis, Thrombosis and Vascular Biology. vol. 35 (11).
- (2015) The inflammatory role of HMGB1 in preeclampsia. Pregnancy Hypertension. vol. 5.
- (2014) Metabolomic biomarkers in serum and urine in women with preeclampsia. PLOS ONE. vol. 9 (3:e91923).
- (2014) OC10.01: A prospective study of screening for hypertensive disorders of pregnancy at 11 to 13 weeks. Ultrasound in Obstetrics and Gynecology. vol. 44 (S1).
- (2014) OP12.01: Risk assessment for pre-eclampsia in nulliparous women at 11 to 13 weeks gestational age: evaluation of two algorithms. Ultrasound in Obstetrics and Gynecology. vol. 44.
- (2014) A prospective study of screening for hypertensive disorders of pregnancy at 11–13 weeks in a Scandinavian population. Acta Obstetricia et Gynecologica Scandinavica. vol. 93 (12).
- (2013) Changes in Levels of Metabolomic Biomarkers in Serum and Urine in Women with Preeclampsia. Magnetic Resonance Materials in Physics, Biology and Medicine. vol. 26 (1).
- (2013) Metabolomic biomarkers in serum and urine of preeclamptic women. Pregnancy Hypertension. vol. 3 (2).
- (2013) A randomized controlled trial of third-trimester routine ultrasound in a non-selected population. Acta Obstetricia et Gynecologica Scandinavica. vol. 92 (12).
Rapport/avhandling
- (2015) Screening for placental dysfunction. The detection of fetal growth restriction and prediction of hypertensive disorders of pregnancy with ultrasound and biochemical markers. 2015. ISBN 9788232609604. Doctoral Thesis (152).
- (2006) The spin-off effect of routine ultrasound in pregnancy: re-examinations after routine ultrasound examination. 2006.